首页> 外文期刊>Endocrine journal >The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism
【24h】

The prevalence of hyperprolactinaemia in overt and subclinical hypothyroidism

机译:高泌乳素血症在明显和亚临床甲状腺功能减退症中的流行

获取原文
获取原文并翻译 | 示例
       

摘要

The aims of this study were to: 1) determine the prevalence of hyperprolactinaemia in patients with newly diagnosed subclinical and overt hypothyroidism, and 2) investigate the change in PRL levels with treatment. In this observational study, patients with a new diagnosis of hypothyroidism in our endocrinology clinic were approached for participation, as were healthy controls. Patients with medical reasons for having elevated PRL levels, lactating and pregnant women were excluded from the study. No patient had kidney or liver disease. After examination to determine if clinical causes of PRL elevation were present, serum levels of thyrotropin (TSH), free thyroxine, free triiodothyronine and PRL were measured and correlation of PRL levels with the severity of hypothyroidism (overt or subclinical) was performed. Fifty-three patients (45 women, 8 men, mean age 45.3±12.2 years) had overt hypothyroidism. One hundred forty-seven patients (131 women, 16 men, mean age 42.9±12.6 years) had subclinical hypothyroidism. One hundred healthy persons (85 women, 15 men, mean age 43.9±11.4 years) participated as controls. The same blood tests were repeated in patients after normalization of TSH levels with L-thyroxine treatment. PRL elevation was found in 36% of patients with overt hypothyroidism, and in 22% of patients with subclinical hypothyroidism. PRL levels decreased to normal in all patients after thyroid functions normalized with L-thyroxine treatment. In the hypothyroid patients (overt and subclinical) a positive correlation was found between TSH and PRL levels (r=0.208,p=0.003). PRL regulation is altered in overt and subclinical hypothyroidism, and PRL levels normalize with appropriate L-thyroxine treatment.
机译:这项研究的目的是:1)确定患有新诊断的亚临床和明显甲状腺功能减退症患者的高泌乳素血症的患病率,以及2)研究治疗后PRL水平的变化。在这项观察性研究中,与我们的内分泌科诊所的甲状腺功能减退症新诊断的患者以及健康对照者进行了接触。由于医学原因导致PRL水平升高,哺乳期和孕妇的患者被排除在研究之外。没有患者有肾脏或肝脏疾病。在检查以确定是否存在PRL升高的临床原因后,测量了血清促甲状腺激素(TSH),游离甲状腺素,游离三碘甲状腺素和PRL的水平,并进行了PRL水平与甲状腺功能减退症严重程度(明显或亚临床)的相关性。 53例患者(45名女性,8名男性,平均年龄45.3±12.2岁)患有明显的甲状腺功能减退症。 147例亚临床甲状腺功能减退症患者(131名女性,16名男性,平均年龄42.9±12.6岁)。一百名健康人(85名女性,15名男性,平均年龄43.9±11.4岁)作为对照组。用L-甲状腺素治疗使TSH水平恢复正常后,对患者重复相同的血液检查。在36%的明显甲状腺功能减退症患者和22%的亚临床甲状腺功能减退症患者中发现PRL升高。 L-甲状腺素治疗使甲状腺功能恢复正常后,所有患者的PRL水平均降至正常。在甲状腺功能减退的患者(明显和亚临床)中,TSH和PRL水平呈正相关(r = 0.208,p = 0.003)。 PRL调节在明显的和亚临床甲状腺功能减退症中发生了改变,并且通过适当的L-甲状腺素治疗可使PRL水平恢复正常。

著录项

  • 来源
    《Endocrine journal》 |2010年第12期|p.1011-1015|共5页
  • 作者单位

    Celal Bayar University, Medical Faculty, Department of Internal Medicine, Division of Endocrinology and Metabolism, Manisa, Turkey;

    Celal Bayar University, Medical Faculty, Department of Internal Medicine, Division of Endocrinology and Metabolism, Manisa, Turkey;

    Celal Bayar University, Medical Faculty, Department of Internal Medicine, Division of Endocrinology and Metabolism, Manisa, Turkey;

    Celal Bayar University, Medical Faculty, Department of Internal Medicine, Division of Endocrinology and Metabolism, Manisa, Turkey;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    hypothyroidism; subclinical hypothyroidism; hyperprolactinemia; prolactin;

    机译:甲状腺功能减退;亚临床甲状腺功能减退症;高泌乳素血症催乳素;
  • 入库时间 2022-08-18 01:33:33

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号